ANGO Stock Analysis
AN
Uncovered
AngioDynamics Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
AngioDynamics, Inc. is a medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options. It operates through two segments, namely Med Tech and Med Device. Its products offerings fall within three global business units: Endovascular Therapies (VIT), Oncology/Surgery (OS) and Vascular Access (VA). Its products include Auryon, Thrombectomy, Peripheral Products (Core), BioFlo, Midlines, Peripherally Inserted Central Catheter (PICC), C3 Wave PICC tip location system, Ports, Dialysis Products, Venous Insufficiency, Microwave Ablation, Radiofrequency Ablation, BioSentry Tract Sealant System, IsoLoc Endorectal Balloon and Alatus Vaginal Balloon Packing System. Its Thrombus Management portfolio includes the AlphaVac System, AngioVac venous drainage system, Thrombolytic catheters and NanoKnife. Its Peripheral Products (Core) include Angiographic Products and Accessories, Drainage Products and Micro Access Kits.